Haemonetics Corporation (NYSE:HAE) Given Consensus Rating of "Moderate Buy" by Brokerages
Haemonetics Corporation (NYSE:HAE - Get Free Report) has earned a consensus rating of "Moderate Buy" from the thirteen ratings firms that are presently covering the stock, MarketBeat Ratings reports...
MarketBeat·1d ago
More News
Fort Washington Investment Advisors Inc. OH Has $34.43 Million Stock Holdings in Haemonetics Corporation $HAE
Fort Washington Investment Advisors Inc. OH boosted its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 36.2% in the 3rd quarter, according to its most recent filing with the SEC. The...
MarketBeat·2d ago
Haemonetics Corporation $HAE Shares Sold by Boston Trust Walden Corp
Boston Trust Walden Corp lessened its stake in Haemonetics Corporation (NYSE:HAE - Free Report) by 12.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange...
MarketBeat·2d ago
Harbor Capital Advisors Inc. Purchases 14,226 Shares of Haemonetics Corporation $HAE
Harbor Capital Advisors Inc. boosted its position in Haemonetics Corporation (NYSE:HAE - Free Report) by 49.7% during the third quarter, according to its most recent disclosure with the Securities...
MarketBeat·6d ago
Assenagon Asset Management S.A. Invests $8.56 Million in Haemonetics Corporation $HAE
Assenagon Asset Management S.A. bought a new position in shares of Haemonetics Corporation (NYSE:HAE - Free Report) in the third quarter, according to the company in its most recent 13F filing with...
MarketBeat·11d ago
Here's Why Haemonetics (HAE) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·13d ago
Haemonetics (NYSE:HAE) Price Target Raised to $90.00
Mizuho upped their target price on Haemonetics from $75.00 to $90.00 and gave the company an "outperform" rating in a research report on Wednesday...
MarketBeat·15d ago
Here's Why Haemonetics (HAE) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·17d ago
Haemonetics (NYSE:HAE) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut shares of Haemonetics from a "buy" rating to a "hold" rating in a research note on Sunday...
MarketBeat·18d ago
Haemonetics (NYSE:HAE) Price Target Raised to $74.00 at JPMorgan Chase & Co.
JPMorgan Chase & Co. lifted their target price on Haemonetics from $62.00 to $74.00 and gave the company a "neutral" rating in a research note on Friday...